Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
25-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #50177
advertisement
Zhou L
41
Showing records 1 to 25 |
Display all abstracts from
Zhou L
128031
A three-tier AI solution for equitable glaucoma diagnosis across China's hierarchical healthcare system
Zhou Y
NPJ digital medicine
2025; 8: 400
128037
Comprehensive characterization of human aqueous humor proteomes from primary open-angle glaucoma using data-independent acquisition dataset on a TimsTOF pro mass spectrometer
Xiao H
Data in brief
2025; 61: 111881
128222
Evaluation of prolonged use of topical glaucoma medications on gonioscopy-assisted transluminal trabeculotomy outcomes in juvenile open-angle glaucoma
Wang Z
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2025; 0: 100240
128031
A three-tier AI solution for equitable glaucoma diagnosis across China's hierarchical healthcare system
Nie H
NPJ digital medicine
2025; 8: 400
128037
Comprehensive characterization of human aqueous humor proteomes from primary open-angle glaucoma using data-independent acquisition dataset on a TimsTOF pro mass spectrometer
Lu DQ
Data in brief
2025; 61: 111881
128222
Evaluation of prolonged use of topical glaucoma medications on gonioscopy-assisted transluminal trabeculotomy outcomes in juvenile open-angle glaucoma
Yang Z
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2025; 0: 100240
128031
A three-tier AI solution for equitable glaucoma diagnosis across China's hierarchical healthcare system
Gong X
NPJ digital medicine
2025; 8: 400
128037
Comprehensive characterization of human aqueous humor proteomes from primary open-angle glaucoma using data-independent acquisition dataset on a TimsTOF pro mass spectrometer
Cheung JK
Data in brief
2025; 61: 111881
128222
Evaluation of prolonged use of topical glaucoma medications on gonioscopy-assisted transluminal trabeculotomy outcomes in juvenile open-angle glaucoma
Liu S; Liu J
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2025; 0: 100240
128031
A three-tier AI solution for equitable glaucoma diagnosis across China's hierarchical healthcare system
Dai M
NPJ digital medicine
2025; 8: 400
128037
Comprehensive characterization of human aqueous humor proteomes from primary open-angle glaucoma using data-independent acquisition dataset on a TimsTOF pro mass spectrometer
Sze YH
Data in brief
2025; 61: 111881
128031
A three-tier AI solution for equitable glaucoma diagnosis across China's hierarchical healthcare system
Guo Z
NPJ digital medicine
2025; 8: 400
128037
Comprehensive characterization of human aqueous humor proteomes from primary open-angle glaucoma using data-independent acquisition dataset on a TimsTOF pro mass spectrometer
Bian JF
Data in brief
2025; 61: 111881
128222
Evaluation of prolonged use of topical glaucoma medications on gonioscopy-assisted transluminal trabeculotomy outcomes in juvenile open-angle glaucoma
Huang C
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2025; 0: 100240
128031
A three-tier AI solution for equitable glaucoma diagnosis across China's hierarchical healthcare system
Deng X
NPJ digital medicine
2025; 8: 400
128037
Comprehensive characterization of human aqueous humor proteomes from primary open-angle glaucoma using data-independent acquisition dataset on a TimsTOF pro mass spectrometer
Do CW
Data in brief
2025; 61: 111881
128222
Evaluation of prolonged use of topical glaucoma medications on gonioscopy-assisted transluminal trabeculotomy outcomes in juvenile open-angle glaucoma
Zhu X; Dang G
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2025; 0: 100240
128031
A three-tier AI solution for equitable glaucoma diagnosis across China's hierarchical healthcare system
Li M
NPJ digital medicine
2025; 8: 400
128037
Comprehensive characterization of human aqueous humor proteomes from primary open-angle glaucoma using data-independent acquisition dataset on a TimsTOF pro mass spectrometer
Zhou L
Data in brief
2025; 61: 111881
128031
A three-tier AI solution for equitable glaucoma diagnosis across China's hierarchical healthcare system
Liu Y
NPJ digital medicine
2025; 8: 400
128037
Comprehensive characterization of human aqueous humor proteomes from primary open-angle glaucoma using data-independent acquisition dataset on a TimsTOF pro mass spectrometer
Xing XL
Data in brief
2025; 61: 111881
128222
Evaluation of prolonged use of topical glaucoma medications on gonioscopy-assisted transluminal trabeculotomy outcomes in juvenile open-angle glaucoma
Yang X
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2025; 0: 100240
128031
A three-tier AI solution for equitable glaucoma diagnosis across China's hierarchical healthcare system
Sun L
NPJ digital medicine
2025; 8: 400
128037
Comprehensive characterization of human aqueous humor proteomes from primary open-angle glaucoma using data-independent acquisition dataset on a TimsTOF pro mass spectrometer
Lam TC
Data in brief
2025; 61: 111881
128222
Evaluation of prolonged use of topical glaucoma medications on gonioscopy-assisted transluminal trabeculotomy outcomes in juvenile open-angle glaucoma
Pan X; Zhou L
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2025; 0: 100240
«
1
2
»
Issue
25-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept